Literature DB >> 32197050

Localization of Macrophages in the Human Lung via Design-based Stereology.

Patrick S Hume1,2, Sophie L Gibbings1, Claudia V Jakubzick3, Rubin M Tuder2, Douglas Curran-Everett4,5, Peter M Henson1,2, Bradford J Smith6, William J Janssen1,2.   

Abstract

Rationale: Interstitial macrophages (IMs) and airspace macrophages (AMs) play critical roles in lung homeostasis and host defense, and are central to the pathogenesis of a number of lung diseases. However, the absolute numbers of macrophages and the precise anatomic locations they occupy in the healthy human lung have not been quantified.
Objectives: To determine the precise number and anatomic location of human pulmonary macrophages in nondiseased lungs and to quantify how this is altered in chronic cigarette smokers.
Methods: Whole right upper lobes from 12 human donors without pulmonary disease (6 smokers and 6 nonsmokers) were evaluated using design-based stereology. CD206 (cluster of differentiation 206)-positive/CD43+ AMs and CD206+/CD43- IMs were counted in five distinct anatomical locations using the optical disector probe.Measurements and Main
Results: An average of 2.1 × 109 IMs and 1.4 × 109 AMs were estimated per right upper lobe. Of the AMs, 95% were contained in diffusing airspaces and 5% in airways. Of the IMs, 78% were located within the alveolar septa, 14% around small vessels, and 7% around the airways. The local density of IMs was greater in the alveolar septa than in the connective tissue surrounding the airways or vessels. The total number and density of IMs was 36% to 56% greater in the lungs of cigarette smokers versus nonsmokers.Conclusions: The precise locations occupied by pulmonary macrophages were defined in nondiseased human lungs from smokers and nonsmokers. IM density was greatest in the alveolar septa. Lungs from chronic smokers had increased IM numbers and overall density, supporting a role for IMs in smoking-related disease.

Entities:  

Keywords:  alveolar; cigarette smokers; emphysema; interstitial; morphometry

Mesh:

Substances:

Year:  2020        PMID: 32197050      PMCID: PMC7233346          DOI: 10.1164/rccm.201911-2105OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   30.528


  47 in total

1.  Tissue shrinkage and unbiased stereological estimation of particle number and size.

Authors:  K A Dorph-Petersen; J R Nyengaard; H J Gundersen
Journal:  J Microsc       Date:  2001-12       Impact factor: 1.758

2.  Architecture of the human lung. Use of quantitative methods establishes fundamental relations between size and number of lung structures.

Authors:  E R WEIBEL; D M GOMEZ
Journal:  Science       Date:  1962-08-24       Impact factor: 47.728

3.  Intra-alveolar macrophage numbers in current smokers and non-smokers: a morphometric study of tissue sections.

Authors:  W A Wallace; M Gillooly; D Lamb
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

Review 4.  A review of recent methods for efficiently quantifying immunogold and other nanoparticles using TEM sections through cells, tissues and organs.

Authors:  Terry M Mayhew; Christian Mühlfeld; Dimitri Vanhecke; Matthias Ochs
Journal:  Ann Anat       Date:  2008-11-30       Impact factor: 2.698

5.  Macrophage Regulation during Vascular Remodeling: Implications for Pulmonary Hypertension Therapy.

Authors:  Soni Savai Pullamsetti; Rajkumar Savai
Journal:  Am J Respir Cell Mol Biol       Date:  2017-05       Impact factor: 6.914

6.  Pulmonary macrophages: alveolar and interstitial populations.

Authors:  B E Lehnert; Y E Valdez; L M Holland
Journal:  Exp Lung Res       Date:  1985       Impact factor: 2.459

7.  Stereology and morphometry of lung tissue.

Authors:  Christian Mühlfeld; Lars Knudsen; Matthias Ochs
Journal:  Methods Mol Biol       Date:  2013

8.  Reversible impairment of the adherence of alveolar macrophages from cigarette smokers.

Authors:  F L Rasp; C C Clawson; J R Hoidal; J E Repine
Journal:  Am Rev Respir Dis       Date:  1978-12

9.  Growth of alveoli during postnatal development in humans based on stereological estimation.

Authors:  Matt J Herring; Lei F Putney; Gregory Wyatt; Walter E Finkbeiner; Dallas M Hyde
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-06-06       Impact factor: 5.464

10.  The nature of small-airway obstruction in chronic obstructive pulmonary disease.

Authors:  James C Hogg; Fanny Chu; Soraya Utokaparch; Ryan Woods; W Mark Elliott; Liliana Buzatu; Ruben M Cherniack; Robert M Rogers; Frank C Sciurba; Harvey O Coxson; Peter D Paré
Journal:  N Engl J Med       Date:  2004-06-24       Impact factor: 91.245

View more
  18 in total

1.  Cigarette smoke-induced airspace disease in mice develops independently of HIF-1α signaling in leukocytes.

Authors:  Patrick S Hume; Jazalle McClendon; Katrina W Kopf; Julie W Harral; Joanna M Poczobutt; Alexandra L McCubbrey; Bradford J Smith; Peter M Henson; Susan M Majka; Irina Petrache; William J Janssen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-08-09       Impact factor: 6.011

Review 2.  Biology of lung macrophages in health and disease.

Authors:  Helena Aegerter; Bart N Lambrecht; Claudia V Jakubzick
Journal:  Immunity       Date:  2022-09-13       Impact factor: 43.474

Review 3.  Pathogenesis of pneumonia and acute lung injury.

Authors:  Matthew E Long; Rama K Mallampalli; Jeffrey C Horowitz
Journal:  Clin Sci (Lond)       Date:  2022-05-27       Impact factor: 6.876

4.  Advancing Lung Immunology Research: An Official American Thoracic Society Workshop Report.

Authors:  Rod A Rahimi; Josalyn L Cho; Claudia V Jakubzick; Shabaana A Khader; Bart N Lambrecht; Clare M Lloyd; Ari B Molofsky; Sebastien Talbot; Catherine A Bonham; Wonder P Drake; Anne I Sperling; Benjamin D Singer
Journal:  Am J Respir Cell Mol Biol       Date:  2022-07       Impact factor: 7.748

5.  A census of the lung: CellCards from LungMAP.

Authors:  Xin Sun; Anne-Karina Perl; Rongbo Li; Sheila M Bell; Eniko Sajti; Vladimir V Kalinichenko; Tanya V Kalin; Ravi S Misra; Hitesh Deshmukh; Geremy Clair; Jennifer Kyle; Laura E Crotty Alexander; Jorge A Masso-Silva; Joseph A Kitzmiller; Kathryn A Wikenheiser-Brokamp; Gail Deutsch; Minzhe Guo; Yina Du; Michael P Morley; Michael J Valdez; Haoze V Yu; Kang Jin; Eric E Bardes; Jarod A Zepp; Terren Neithamer; Maria C Basil; William J Zacharias; Jamie Verheyden; Randee Young; Gautam Bandyopadhyay; Sara Lin; Charles Ansong; Joshua Adkins; Nathan Salomonis; Bruce J Aronow; Yan Xu; Gloria Pryhuber; Jeff Whitsett; Edward E Morrisey
Journal:  Dev Cell       Date:  2021-12-21       Impact factor: 13.417

6.  The angiocrine Rspondin3 instructs interstitial macrophage transition via metabolic-epigenetic reprogramming and resolves inflammatory injury.

Authors:  Bisheng Zhou; Lissette Magana; Zhigang Hong; Long Shuang Huang; Sreeparna Chakraborty; Yoshikazu Tsukasaki; Cary Huang; Li Wang; Anke Di; Balaji Ganesh; Xiaopei Gao; Jalees Rehman; Asrar B Malik
Journal:  Nat Immunol       Date:  2020-08-24       Impact factor: 25.606

7.  Single-Nucleus RNA-Sequencing Profiling of Mouse Lung. Reduced Dissociation Bias and Improved Rare Cell-Type Detection Compared with Single-Cell RNA Sequencing.

Authors:  Jeffrey R Koenitzer; Haojia Wu; Jeffrey J Atkinson; Steven L Brody; Benjamin D Humphreys
Journal:  Am J Respir Cell Mol Biol       Date:  2020-12       Impact factor: 6.914

Review 8.  Role of Innate Immune System in Environmental Lung Diseases.

Authors:  Marissa A Guttenberg; Aaron T Vose; Robert M Tighe
Journal:  Curr Allergy Asthma Rep       Date:  2021-05-10       Impact factor: 4.806

9.  The ex vivo perfused human lung is resistant to injury by high-dose S. pneumoniae bacteremia.

Authors:  James T Ross; Nicolas Nesseler; Aleksandra Leligdowicz; Rachel L Zemans; Rahul Y Mahida; Emily Minus; Chaz Langelier; Jeffrey E Gotts; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-06-10       Impact factor: 6.011

10.  Know Where You Are: Pulmonary Macrophage Locations in the Human Lung.

Authors:  Robert M Tighe; Yen Rei Yu
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.